This compound is a Boc-protected thienopyridine derivative used as a pharmaceutical intermediate. It features a fused ring system containing both sulfur and nitrogen, commonly employed in the synthesis of active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 230301-73-2
1,1-Dimethylethyl N-[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]carbamate
Boc-protected pharmaceutical intermediate
(S)-tert-Butyl (1-oxo-1-phenylhex-5-yn-2-yl)carbamate
Boc-protected pharmaceutical intermediate
9beta,10alpha-Pregna-4,6,8(14)-triene-3,20-dione
Pharmaceutical intermediate for dydrogesterone synthesis
Benzyloxycarbonylasparagine
protected amino acid for peptide synthesis
(1R,2R)-(-)-1,2-CYCLOHEXANEDICARBOXYLIC ACID
Pharmaceutical intermediate for API synthesis
3'-O-Methyl-5-methyluridine
Pharmaceutical intermediate for nucleoside analogs
5-nitroso-4H,5H,6H,7H-thieno[3,2-c]pyridine
pharmaceutical impurity reference standard
4,5,6,7-Tetrahydrothieno(3,2-c)pyridinium chloride
pharmaceutical intermediate
tert-butyl 6,7-dihydro-4H-thieno[3,2-c]pyridine-5-carboxylate
DGYXRUYCQAYVDM-UHFFFAOYSA-N
CC(C)(C)OC(=O)N1CCC2=C(C1)C=CS2
—